Johnson and Johnson Earnings Call, Fourth Quarter 2008
Author: Maclintosh Kuhlengisa
123jump.com
Last Update: 6:21 PM ET January 21 2009
The pharmaceutical firm realized a 5% dip in sales to $15 billion due to negative currency impact. Lower cost of goods drove a 14% rise in income to $2.7 billion or 97 cents a share as it continues to make progress in the research pipelines while investing in the future growth of the business.
Sources: Data collected by 123jump.com and Ticker.com from company press releases, filings and corporate websites.
Market data: BATS Exchange. Inc.
350 Fund Managers Interviews - 10-year Annual earnings on 4,600 U.S. companies - 20-quarter Earnings on 3,800 U.S. companies - 3,200 U.S. IPO Prospectuses
- 2,100 Economic data releases from U.S., EU, UK, India, HK and Australia. 10-year Annual reports on 3,500 U.S. companies -
U.S. Earnings Calendar with 4,800 companies - 90,000 10-K reports - 26,000 Global markets news archive - 2,200 Earnings Conference Call Summaries
